David Holland MD, MHS
- Department of Medicine
Adjunct Assistant Professor
- (678) 843-8600
- david.holland@emory.edu
-
Fulton County Board of Health
Communicable Disease Prevention Branch
10 Park Place SE -
Emory University
49 Jesse Hill Jr Dr SE
Overview
Dr. Holland is an Associate Professor at Emory in the School of Medicine (Department of Medicine, Division of Infectious Diseases) who also serves as the Chief Clinical Officer for the Fulton County Board of Health. His research aims at improving the efficiency of clinical trials and finding innovations in public health initiatives. His previous projects have focused on the use of decision analysis in the planning phase of clinical trials in an effort to identify the most economically viable potential regimens prior to conducting large-scale studies. In particular, he collaborated with scientists and economists from the Centers for Disease Control and Prevention on cost-effectiveness analyses that have informed current guidelines for the treatment of latent tuberculosis infection and identified areas for future research that are of high value to current policymakers. His clinical interests include treatment and prevention of tuberculosis, sexually transmitted infections, and HIV infection (including pre-exposure prophylaxis).
Academic Appointment
- Senior Physician, Emory University School of Medicine
- Associate Professor, Medicine, Emory University
Education
Degrees
- MD from Emory University
- MHS from Duke University
- BS from Millsaps College
Research
Publications
-
Impact of Depression at HIV PrEP Initiation on Sustained PrEP Care Engagement Among US Gay and Bisexual Men.
J Acquir Immune Defic Syndr
05/15/2025 Authors: Onwubiko UN; Benkeser D; Holland DP; Baral SD; Marcus JL; Mayer KH; Herrick B; Sinha P; Chamberlain AT; Jenness SM -
Exploring Willingness to Use Long-Acting Injectable PrEP Among Sexual and Gender Minoritized People Accessing Pharmacies.
AIDS Educ Prev Volume: 37 Page(s): 107 - 125
04/01/2025 Authors: Alohan DI; Chandra C; Young HN; Quamina A; Holland DP; Crawford ND -
Individual & joint associations of sexual stigma and mental distress with PrEP uptake, adherence and persistence among US gay and bisexual men.
Soc Sci Med Volume: 363 Page(s): 117493
12/01/2024 Authors: Onwubiko UN; Murray SM; Rao A; Chamberlain AT; Sanchez TH; Benkeser D; Holland DP; Jenness SM; Baral SD -
Structural Influences on Methamphetamine Use Among Black Sexual Minority Men (HISTORY Study): Protocol for a Longitudinal Cohort Study.
JMIR Res Protoc Volume: 13 Page(s): e63761
10/31/2024 Authors: Opara SCO; Linton SL; Weir BW; Crawford ND; Holland DP; Newman A; Bullock M; Reed MO; Dutta S; Doraivelu K -
Development of a Machine Learning Modeling Tool for Predicting HIV Incidence Using Public Health Data From a County in the Southern United States.
Clin Infect Dis Volume: 79 Page(s): 717 - 726
09/26/2024 Authors: Saldana CS; Burkhardt E; Pennisi A; Oliver K; Olmstead J; Holland DP; Gettings J; Mauck D; Austin D; Wortley P -
Reversing Inequity in Mpox Vaccine Distribution, Fulton County, Georgia, June-September 2022.
Am J Public Health Volume: 113 Page(s): 1263 - 1266
12/01/2023 Authors: O'Neal J; Lopes da Rosa J; Astin M; Folkes D; Crowder D; Holland DP -
Comparing open-ended question methods to vignette methods to explore willingness to obtain pre-exposure prophylaxis access in pharmacies among black men who have sex with men.
AIDS Care Volume: 35 Page(s): 1955 - 1962
12/01/2023 Authors: Josma D; Morris J; Hopkins R; Quamina A; Siegler AJ; Holland D; S Sullivan P; Harrington KRV; Alohan DI; Crawford ND -
Exploring the Association Between Indicators of Socioeconomic Instability, Survival Sex, and Methamphetamine Use Among Young Adult Black Gay, Bisexual, and Other Men Who Have Sex With Men: A Cross-Sectional Study.
J Assoc Nurses AIDS Care Volume: 34 Page(s): 538 - 547
11/01/2023 Authors: Curtis MG; Reed M; Newman A; Doraivelu K; Patel SA; Crawford ND; Holland DP; Hussen SA -
Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection.
Clin Infect Dis Volume: 76 Page(s): 2090 - 2097
06/16/2023 Authors: Sadowski C; Belknap R; Holland DP; Moro RN; Chen MP; Wright A; Millet JP; Cayl JA; Scott NA; Borisov A -
Using a medication event monitoring system to evaluate self-report and pill count for determining treatment completion with self-administered, once-weekly isoniazid and rifapentine.
Contemp Clin Trials Volume: 129 Page(s): 107173
06/01/2023 Authors: Scott NA; Sadowski C; Vernon A; Arevalo B; Beer K; Borisov A; Cayla JA; Chen M; Feng P-J; Moro RN